Aerovate Therapeutics, Inc. AVTE
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover GP I, LLC | Delaware | 0 | 2201274 | 0 | 2201274 | 2201274 | 8 % | 09/02/2024 |
| TCG Crossover Fund I, L.P. | Delaware | 0 | 2201274 | 0 | 2201274 | 2201274 | 8 % | 09/02/2024 |
| Chen Yu | United States of America | 0 | 2201274 | 0 | 2201274 | 2201274 | 8 % | 09/02/2024 |
| Julian C. Baker | United States | 1831789 | 0 | 1831789 | 0 | 1831789 | 7.5 % | 14/02/2022 |
| Baker Bros. Advisors LP | Delaware | 1831789 | 0 | 1831789 | 0 | 1831789 | 7.5 % | 14/02/2022 |
| Felix J. Baker | United States | 1831789 | 0 | 1831789 | 0 | 1831789 | 7.5 % | 14/02/2022 |
| Baker Bros. Advisors (GP) LLC | Delaware | 1831789 | 0 | 1831789 | 0 | 1831789 | 7.5 % | 14/02/2022 |
| Cormorant Private Healthcare GP II, LLC | Delaware | 0 | 1211696 | 0 | 1211696 | 1211696 | 4.96 % | 14/02/2022 |
| Cormorant Asset Management, LP | Delaware | 0 | 1830691 | 0 | 1830691 | 1830691 | 7.5 % | 14/02/2022 |
| Bihua Chen | United States | 0 | 1830691 | 0 | 1830691 | 1830691 | 7.5 % | 14/02/2022 |
| Cormorant Global Healthcare Master Fund, LP | Cayman Islands | 0 | 618995 | 0 | 618995 | 618995 | 2.54 % | 14/02/2022 |
| Cormorant Private Healthcare Fund II, LP | Delaware | 0 | 1211696 | 0 | 1211696 | 1211696 | 4.96 % | 14/02/2022 |
| Cormorant Global Healthcare GP, LLC | Delaware | 0 | 618995 | 0 | 618995 | 618995 | 2.54 % | 14/02/2022 |
| 2. | 0 | 1597479 | 0 | 0 | 10 | 6.5 % | 14/02/2022 | |
| 2. | 0 | 1592517 | 0 | 0 | 10 | 6.5 % | 14/02/2022 | |
| 2. | 0 | 1592517 | 0 | 0 | 10 | 6.5 % | 14/02/2022 | |
| 2. | 0 | 1592517 | 0 | 0 | 10 | 6.5 % | 14/02/2022 | |
| 2. | 0 | 4962 | 0 | 0 | 10 | 0 % | 14/02/2022 | |
| 2. | 0 | 4962 | 0 | 0 | 10 | 0 % | 14/02/2022 | |
| 2. | 0 | 4962 | 0 | 0 | 10 | 0 % | 14/02/2022 | |
| Atlas Venture Fund XII, L.P. | Delaware | 0 | 3103879 | 0 | 10 | 3103879 | 12.7 % | 05/11/2021 |
| Atlas Venture Associates XII, LLC | Delaware | 0 | 3103879 | 0 | 10 | 3103879 | 12.7 % | 05/11/2021 |
| Atlas Venture Associates XII, L.P. | Delaware | 0 | 3103879 | 0 | 10 | 3103879 | 12.7 % | 05/11/2021 |
| Sofinnova Management X, L.L.C. (“SM X”) | Delaware | 3758686 | 0 | 3758686 | 0 | 3758686 | 16.3 % | 13/07/2021 |
| Dr. James I. Healy (“Healy”) | U.S. Citizen | 0 | 3758686 | 0 | 10 | 3758686 | 16.3 % | 13/07/2021 |
| Sofinnova Venture Partners X, L.P. (“SVP X”) | Delaware | 3758686 | 0 | 3758686 | 10 | 3758686 | 16.3 % | 13/07/2021 |
| Dr. Maha Katabi (“Katabi”) | Canadian Citizen | 1388 | 3758686 | 1388 | 10 | 3760074 | 16.3 % | 13/07/2021 |
| RA Capital Management, L.P. | Delaware | 0 | 8263982 | 0 | 10 | 8263982 | 33.9 % | 12/07/2021 |
| Peter Kolchinsky | United States | 0 | 8263982 | 0 | 10 | 8263982 | 33.9 % | 12/07/2021 |
| Rajeev Shah | United States | 0 | 8263982 | 0 | 10 | 8263982 | 33.9 % | 12/07/2021 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 6965568 | 0 | 10 | 6965568 | 28.5 % | 12/07/2021 |
| Cormorant Private Healthcare Fund II, LP | Delaware | 0 | 1211696 | 0 | 1211696 | 1211696 | 4.96 % | 12/07/2021 |
| Cormorant Global Healthcare GP, LLC | Delaware | 0 | 818995 | 0 | 818995 | 818995 | 3.36 % | 12/07/2021 |
| Bihua Chen | United States | 0 | 2030691 | 0 | 2030691 | 2030691 | 8.32 % | 12/07/2021 |
| Cormorant Global Healthcare Master Fund, LP | Cayman Islands | 0 | 818995 | 0 | 818995 | 818995 | 3.36 % | 12/07/2021 |
| Cormorant Private Healthcare GP II, LLC | Delaware | 0 | 1211696 | 0 | 1211696 | 1211696 | 4.96 % | 12/07/2021 |
| Cormorant Asset Management, LP | Delaware | 0 | 2030691 | 0 | 2030691 | 2030691 | 8.32 % | 12/07/2021 |
| Citadel Advisors Holdings LP | Delaware | 0 | 1613831 | 0 | 1613831 | 6 | 6.6 % | 12/07/2021 |